PFS Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3K Buy
281
+5
+2% +$25 ﹤0.01% 557
2026
Q1
$1.28K Buy
276
+4
+1% +$21 ﹤0.01% 545
2025
Q4
$1.36K Buy
272
+4
+1% +$21 ﹤0.01% 538
2025
Q3
$1.36K Buy
268
+5
+2% +$22 ﹤0.01% 519
2025
Q2
$1.13K Buy
263
+5
+2% +$25 ﹤0.01% 474
2025
Q1
$1.56K Buy
258
+5
+2% +$25 ﹤0.01% 400
2024
Q4
$1K Buy
253
+4
+2% +$18 ﹤0.01% 416
2024
Q3
$1.46K Buy
249
+8
+3% +$39 ﹤0.01% 410
2024
Q2
$1.04K Buy
241
+8
+3% +$38 ﹤0.01% 406
2024
Q1
$1.1K Buy
233
+9
+4% +$34 ﹤0.01% 425
2023
Q4
$1.1K Buy
224
+6
+3% +$29 ﹤0.01% 421
2023
Q3
$1.19K Buy
218
+6
+3% +$48 ﹤0.01% 421
2023
Q2
$1.96K Buy
212
+7
+3% +$59 ﹤0.01% 421
2023
Q1
$1.68K Buy
205
+5
+3% +$55 ﹤0.01% 342
2022
Q4
$2.23K Buy
+200
New +$2.33K ﹤0.01% 313

Other funds holding MPT

PFS Partners's MPT Position: Q2 2026 in Review

PFS Partners increased its Medical Properties Trust (MPT) stake by 1.8% in Q2 2026, buying an estimated $25 and bringing the position to 281 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #557.

PFS Partners first reported a position in MPT in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.23K in Q4 2022. 158 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • PFS Partners held 281 shares of Medical Properties Trust worth $1.3K as of Q2 2026.
  • PFS Partners bought 5 Medical Properties Trust shares in Q2 2026, an estimated $25.
  • Medical Properties Trust made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #557 holding.
  • PFS Partners first reported a position in Medical Properties Trust in Q4 2022 and has held it in 15 quarters since.
  • PFS Partners's Medical Properties Trust position peaked at $2.23K in Q4 2022.
  • 158 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.